Private Equity
Englewood Cliffs, New Jersey-based Dynamk Capital, a venture fund focused on providing funding to life science tools and service providers, has hired four advisers. They are Dr. Kevin Bailey, Dr. Barry Buckland, Anthony Maddaluna and Dr. Gustavo Mahler.
3 min read · 19 June 2018
3 min read · 18 June 2018
American Vision Partners, which is backed by H.I.G. Capital, has acquired Miles Eye Center, an Arizona-based eye care provider. No financial terms were disclosed. Miles Eye Center will operate under the name of Barnet Dulaney Perkins Eye Center.
3 min read · 18 June 2018
A unit of Chinese investment firm CITIC Capital Holdings Ltd said on Monday it has offered to buy U.S.-listed biotech firm China Biologic Products Holdings Inc (CBPO.O), in a deal valuing the company at $3.65 billion.
1 min read · 18 June 2018
Silverado, a memory care provider, has secured $45 million in funding. The investor was Artemis Real Estate Partners. Coker Capital Advisors was financial adviser to Silverado on the deal. The capital will be used to develop Silverado's memory care communities and support its hospice, palliative care and at home offerings. In addition to the funding, Kelly Sheehy, a principal and managing director of Artemis, will join Silverado’s board of directors.
4 min read · 18 June 2018
Leerink Capital Partners hired ex-Wilshire Private Markets executive Karl Beinkampen as president. Beinkampen worked as president and chief investment officer of Wilshire Private Markets from 2010 to 2018. Prior to Wilshire, Beinkampen worked at Morgan Stanley for 15 years. Leerink Capital Partners was formed in 2013 as a multi-strategy, healthcare-focused principal investing business.
3 min read · 18 June 2018
Lorient Capital is seeking to raise $122 million for its healthcare fund, according to an SEC filing. Co-founders Mark Mitchell and David Berman currently serve as managing partners of the Birmingham, Michigan-based private equity firm.
1 min read · 15 June 2018
West Chester, Pennsylvania-based Verrica Pharmaceuticals, a developer of products that treat skin diseases, has raised $75 million for its IPO after pricing its 5 million share at $15 per share. The stock began trading June 15, 2018 on the NASDAQ under the ticker symbol "VRCA." BofA Merrill Lynch, Jefferies and Cowen are the lead underwriters. Verrica's pre-IPO backers include PBM Capital Group and OrbiMed.
2 min read · 15 June 2018
GI Partners agreed to buy California Cryobank, a donor sperm and egg bank, and Cord Blood Registry, a stem cell collection and storage company. GI plans to combine the two companies, which will serve about 600,000 families across more than 30 countries. The combined deal is expected to close in the third quarter. The deal will be GI’s fifth platform investment from Fund V, which closed on $2.8 billion last year.
3 min read · 15 June 2018
2 min read · 14 June 2018
